Global Breast Implants Market, by Product Type (Saline Implant and Silicone Implant), by Shape (Round and Anatomical), by Application (Breast Augmentation and Breast Reconstruction), by Texture (Smooth and Textured), by End User (Hospitals, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 1,299.9 million in 2021 and expected to exhibit a CAGR of 4.2% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Key players operating in the market are focusing on product launch and this is expected to drive the market growth over the forecast period.
For instance, in September 2020, POLYTECH Health & Aesthetic GmbH, a global leader in breast aesthetics, introduced a B-Lite, world’s first and only lightweight breast implant.
Moreover, in December 2020, Establishement Labs Holdings Inc, a medical technology company focused on women’s health, received CE mark for its next generation Motiva Ergonomix2 silicone breast implant platform. The CE mark also includes the Motiva Ergonomix2 Diamond breast implant, an implant that will be used in Motiva Mia minimally invasive breast augmentation system when it is approved.
Global Breast Implants Market – Impact of Coronavirus (Covid-19) Pandemic
Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 281,808,270 cases and 5,411,759 deaths due to coronavirus disease (COVID-19) were reported till December 29, 2021, across the globe.
The COVID-19 pandemic and lockdown in various countries across the globe has negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions.
For instance, according to America Society of Plastic Surgeons the number of breast augmentation procedures were performed in 2019 were 287, 085 the number went down to 193,073 in 2020.
Browse 42 Market Data Tables and 38 Figures spread through 154 Pages and in-depth TOC on “Breast Implants Market”- Global Forecast to 2028, by Product Type (Saline Implant and Silicone Implant), by Shape (Round and Anatomical), by Application (Breast Augmentation and Breast Reconstruction), by Texture (Smooth and Textured), by End User (Hospitals, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa),
To know the latest trends and insights prevalent in the global breast implants market, click the link below:
https://www.coherentmarketinsights.com/market-insight/breast-implants-market-1309
Key players operating in the market are focusing on adoption of inorganic growth strategies such as mergers, collaborations, partnerships, and acquisitions, in order to strengthen their position in the global market. For instance, in April 2021, Sientra and Butterfly Network entered into a strategic partnership to improve diagnostic surveillance of breast implants patients.
Key Takeaways of the Global Breast Implants Market:
The global breast implants market is expected to exhibit a CAGR of 4.2% over the forecast period, owing to rising launches and regulatory approvals of products. For instance, in May 2021, GC Aesthetics, Inc., launched its next generation of breast implants, PERLE.
Among product type, silicone implants is expected to account for largest market share during the forecast period, owing to their qualities like they feels more like a natural breast.
Key players operating in the global breast implants market include Abbvie, Inc, CEREPLAS, Establishment Labs S.A., GC Aesthetics, GROUPE SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co., Ltd., HansBiomed Co., Ltd, Ideal Implant Inc, Laboratoires Anios, Mentor Worldwide LLC, Polytech Health & Aesthetics GmbH, Shanghai Kangning Medical Device Co., Ltd, Sientra, Inc, and Silimed.
